Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: Gender-age interactions

International Clinical Psychopharmacology

Volumn 22, Issue 4, 2007, Pages 226-229

  Papakostas, George I ^a   Kornstein, Susan G ^b   Clayton, Anita H ^c   Soares, Claudio N ^e   Hallett, Lindsay A ^a   Krishen, Alok ^d   Tucker, Vivian L ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d GLAXOSMITHKLINE   (United States)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

Age; Bupropion; Depression; Gender; Major depressive disorder; Response; Selective serotonin reuptake inhibitors

Indexed keywords

AMFEBUTAMONE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGE DISTRIBUTION; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; AGE FACTORS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS;

EID: 34249062650     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/YIC.0b013e32819f8400     Document Type: Article

References (30)

1. Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, et al. (1995). Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 56:395-401.
2. Bech P, Gram LF, Dein E, Jacobsen O, Vitger J, Bolwig TG (1975). Quantitative rating of depressive states. Acta Psychiatr Scand 51:161-170.
3. Berlanga C, Flores-Ramos M (2006). Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine. J Affect Disord 95:119-123.
4. Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, et al. (2006). Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 double-blind, placebo-controlled trials. J Clin Psychiatry 67:736-746.
5. Cleary P, Guy W (1997). Factor analysis of the Hamilton Depression Scale. Drugs Under Exp Clin Res 1:115-120.
6. Cohen LS, Soares CN, Joffe H (2005). Diagnosis and management of mood disorders during the menopausal transition. Am J Med 118 (Suppl 12B):93-97.
7. Coleman CC, Cunningham LA, Foster VJ, Batey SR, Donahue RM, Houser TL, et al. (1999). Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment. Ann Clin Psychiatry 11:205-215.
8. Coleman CC, King BR, Bolden-Watson C, Book MJ, Segraves RT, Richard N, et al. (2001). A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Ther 23:1040-1058.
9. Croft H, Settle E Jr, Houser T, Batey SR, Donahue RM, Ascher JA (1999). A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther 21:643-658.
10. Davidson J, Pelton S (1986). Forms of atypical depression and their response to antidepressant drugs. Psychiatry Res 17:87-95.
11. Feighner JP, Gardner EA, Johnston JA, Batey SR, Khayrallah MA, Ascher JA, et al. (1991). Double-blind comparison of bupropion and fluoxetine in depressed outpatients. J Clin Psychiatry 52:329-335.
12. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
13. Hildebrandt MG, Steyerberg EW, Stage KB, Passchier J, Kragh-Soerensen P, Danish University Antidepressant Group (2003). Are gender differences important for the clinical effects of antidepressants? Am J Psychiatry 160:1643-1650.
14. International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) guidelines. Available at: http://www.ich.org. Last accessed 15 August 2006.
15. Kavoussi RJ, Segraves RT, Hughes AR, Ascher JA, Johnston JA (1997). Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients. J Clin Psychiatry 58:532-537.
16. Kennedy SH, Fulton K, Bagby MR, Green AL, Cohen NL, Rafi-Tari S (2006). Sexual function during bupropion or paroxetine treatment of major depressive disorder. Can J Psychiatry 51:234-242.
17. Kornstein SG, Harvey AT, Rush AJ, Wisniewski SR, Trivedi MH, Svikis DS, et al. (2005). Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression. Psychol Med 35:683-692.
18. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, et al. (2000). Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 157:1445-1552.
19. Lewis-Hall FC, Wilson MG, Tepner RG, Koke SC (1997). Fluoxetine vs. tricyclic antidepressants in women with major depressive disorder. J Womens Health 6:337-343.
20. Martenyi F, Dossenbach M, Mraz K, Metcalfe S (2001). Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile. Eur Neuropsychopharmacol 11:227-232.
21. Nelder JA, Wedderburn RWM (1972). Generalized Linear Models. J Royal Stat Soc A 135:370-384.
22. Papakostas GI (2006). Dopaminergic-based pharmacotherapies for depression. Eur Neuropsychopharmacol 16:391-402.
23. Post RM, Altshuler LL, Leverich GS, Frye MA, Nolen WA, Kupka RW, et al. (2006). Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 189:124-131.
24. Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, et al. (2006). Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 354:1231-1242.
25. Sloan DM, Kornstein SG (2003). Gender differences in depression and response to antidepressant treatment. Psychiatr Clin North Am 26:581-594.
26. Soares CN (2005). Insomnia in women: an overlooked epidemic? Arch Women's Ment Health 8:205-213.
27. Soares CN, Joffe H, Steiner M (2004). Menopause and mood. Clin Obstet Gynecol 47:576-591.
28. Thase ME, Entsuah R, Cantillon M, Kornstein SG (2005a). Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions. J Womens Health (Larchmt) 14:609-616.
29. Thase ME, Haight BR, Richard N, Rockett CB, Mitton M, Modell JG, et al. (2005b). Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry 66:974-981.
30. Weihs KL, Settle EC Jr, Batey SR, Houser TL, Donahue RM, Ascher JA (2000). Bupropion sustained release versus paroxetine for the treatment of depression in the elderly. J Clin Psychiatry 61:196-202.